文献速递肝病

开发一种新型衰弱指数以预测终末期肝病患者的死亡率

Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
PubMed 文献 · Hepatology · 2017-06-28

在单中心连续纳入536例无MELD例外的肝移植等待名单肝硬化门诊患者,构建由握力、椅立和平衡三项组成的衰弱指数。该指数与MELDNa联合使3个月等待名单死亡风险排序的C统计量从0.80(MELDNa)和0.76(衰弱指数)升至0.82,总NRI为19%(P<0.001)。

要点

  • 衰弱指数由握力、椅立和平衡三项体能指标组成。
  • MELDNa联合衰弱指数3个月等待名单死亡风险C统计量为0.82。
  • 联合模型总NRI为19%(P<0.001),正确重分类16%的死亡/除名(P=0.005)。

核心结论

  • 由三项体能指标组成的肝硬化衰弱指数对衰弱概念具有结构效度,并在MELDNa基础上改善等待名单死亡风险预测。

研究设计与样本

  • 在单中心连续纳入无MELD例外的肝移植等待名单肝硬化门诊患者,共536例,中位MELDNa为18。
  • 采用候选衰弱指标评估,通过Cox回归最佳子集选择分析识别预测等待名单死亡(死亡或因病除名)的指标组合。
  • 以统计准确性与临床实用性平衡选择衰弱指数,并用净重分类指数(NRI)评估将衰弱指数加入MELDNa后正确重分类的患者百分比。

主要发现

  • 107例(20%)死亡或被除名。
  • 最终衰弱指数由握力、椅立和平衡组成。
  • MELDNa与衰弱指数按3个月等待名单死亡风险正确排序患者的能力(一致性统计量)分别为0.80和0.76,两者联合为0.82。
  • 与单独MELDNa相比,MELDNa联合衰弱指数正确重分类16%的死亡/除名(P=0.005)和3%的非死亡/非除名(P=0.17),总NRI为19%(P<0.001)。
  • 与衰弱指数评分良好(<第20百分位)者相比,评分差(>第80百分位)的肝硬化患者在步速、工具性日常生活活动困难、疲惫和低体力活动方面受损更重(每项P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Cirrhosis is characterized by muscle wasting, malnutrition, and functional decline that confer excess mortality not well quantified by the Model for End-Stage Liver Disease (MELD) Sodium (MELDNa) score. We aimed to develop a frailty index to capture these extrahepatic complications of cirrhosis and enhance mortality prediction in patients with cirrhosis. Consecutive outpatients listed for liver transplantation at a single transplant center without MELD exceptions were assessed with candidate frailty measures. Best subset selection analyses with Cox regression identified subsets of frailty measures that predicted waitlist mortality (=death or delisting because of sickness). We selected the frailty index by balancing statistical accuracy with clinical utility. The net reclassification index (NRI) evaluated the %patients correctly reclassified by adding the frailty index to MELDNa. Included were 536 patients with cirrhosis with median MELDNa of 18. One hundred seven (20%) died/were delisted. The final frailty index consisted of: grip strength, chair stands, and balance. The ability of MELDNa and the frailty index to correctly rank patients according to their 3-month waitlist mortality risk (i.e., concordance-statistic) was 0.80 and 0.76, respectively, but 0.82 for MELDNa+frailty index together. Compared with MELDNa alone, MELDNa+frailty index correctly reclassified 16% of deaths/delistings (P = 0.005) and 3% of nondeaths/delistings (P = 0.17) with a total NRI of 19% (P < 0.001). Compared to those with robust frailty index scores (<20th percentile), cirrhotics with poor frailty index scores (>80th percentile) were more impaired by gait speed, difficulty with Instrumental Activities of Daily Living, exhaustion, and low physical activity (P < 0.001 for each). CONCLUSION: Our frailty index for patients with cirrhosis, comprised of three performance-based metrics, has construct validity for the concept of frailty and improves risk prediction of waitlist mortality over MELDNa alone. (Hepatology 2017;66:564-574).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lai JC, Covinsky KE, Dodge JL, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017. PMID: 28422306. doi:10.1002/hep.29219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。